Drug safety data as reported by the U.S. Food & Drug Administration's Web site is plagued by misspellings and an ill-formatted data structure. Brian Overstreet of Adverse Events explains how the company's new filtering technology refinesand demystifies this FDA data. Host Scott Mace asks him what assurances does Adverse Events provide for its own take on the data. Overstreet also explains this summer's move by the FDA to open comments on pharmaceutical companies' Facebook pages prompted a number of those companies to take down those pages. They also discuss the possibility of increased FDA regulation of Internet-based health information, and how individuals who gather their information inside social networks would be made aware of better information available elsewhere on the Internet.
Brian Overstreet, AdverseEvents, Inc. (AEI), manages the company’s strategy and operations. He brings more than fifteen years of experience building and managing companies in the data, research and investment industries.
Prior to joining AEI, Overstreet co-founded Sagient Research Systems, Inc., publisher of specialized research and data, where he served as president and CEO of the company for ten years, and currently serves as chairman. While at Sagient Research, Overstreet was responsible for the development, production and sale of Sagient’s proprietary research products to global enterprises including pharmaceutical companies, investment banks, mutual and hedge funds, academic institutions and government agencies. During his tenure at Sagient Research, the company was named to the Inc. 5000 list of fastest growing U.S. private companies, and continued to remain on the list for four consecutive years. Prior to Sagient Research, Overstreet was the managing director and head of U.S. operations for Midori Corporation and Midori Securities, a privately-held investment bank. While at Midori, Overstreet focused on raising private capital for small U.S. public companies and successfully managed over $150 million in financing transactions.
More recently, Overstreet co-founded Bruliam Wines with his wife, Dr. Kerith Overstreet. As a boutique California winery that has earned a number of 90+ point scores from Wine Enthusiast magazine, Bruliam Wines donate 100 percent of all profits to charity.
Overstreet earned a B.A. in Political Science from the University of California at Berkeley.
Resources
This free podcast is from our Opening Move series.
For The Conversations Network: